203 related articles for article (PubMed ID: 37404182)
21. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
22. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
23. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
[TBL] [Abstract][Full Text] [Related]
24. [Lethal, non-menstrual toxic shock syndrome associated with Staphylococcus aureus sepsis].
Raumanns J; Kaufhold A; Behrendt W; Peters G
Anaesthesist; 1995 Dec; 44(12):869-74. PubMed ID: 8594962
[TBL] [Abstract][Full Text] [Related]
25. Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome.
Scott DF; Kling JM; Best GK
Infect Immun; 1986 Aug; 53(2):441-4. PubMed ID: 3733224
[TBL] [Abstract][Full Text] [Related]
26. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
27. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
28. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
Sikorska H; Smoragiewicz W
Int J Antimicrob Agents; 2013 Dec; 42(6):475-81. PubMed ID: 24071026
[TBL] [Abstract][Full Text] [Related]
29. Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.
Lin YC; Anderson MJ; Kohler PL; Strandberg KL; Olson ME; Horswill AR; Schlievert PM; Peterson ML
Biochemistry; 2011 Aug; 50(33):7157-67. PubMed ID: 21749039
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.
Parsonnet J; Goering RV; Hansmann MA; Jones MB; Ohtagaki K; Davis CC; Totsuka K
J Clin Microbiol; 2008 Aug; 46(8):2731-8. PubMed ID: 18550735
[TBL] [Abstract][Full Text] [Related]
31. Effect of trace metals on the synthesis of toxic shock syndrome toxin 1.
Reeves MW
Rev Infect Dis; 1989; 11 Suppl 1():S145-49; discussion S149-50. PubMed ID: 2928630
[TBL] [Abstract][Full Text] [Related]
32. Lactobacilli require physical contact to reduce staphylococcal TSST-1 secretion and vaginal epithelial inflammatory response.
Younes JA; Reid G; van der Mei HC; Busscher HJ
Pathog Dis; 2016 Jun; 74(4):ftw029. PubMed ID: 27060097
[TBL] [Abstract][Full Text] [Related]
33. Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad.
Adesiyun AA; Singh D; Gunness RI
Zentralbl Bakteriol; 1994 Jan; 280(3):371-81. PubMed ID: 8167431
[TBL] [Abstract][Full Text] [Related]
34. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
[TBL] [Abstract][Full Text] [Related]
35. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
Jacobson JA; Kasworm E; Daly JA
Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
[TBL] [Abstract][Full Text] [Related]
36. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
37. Staphylococcus aureus producing toxic shock syndrome toxin 1 (TSST-1) in clinical specimens and vaginal swabs in Mannheim, West Germany.
Dickgiesser N; Brombacher A
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):323-9. PubMed ID: 3314262
[TBL] [Abstract][Full Text] [Related]
38. The SaeRS Two-Component System Is a Direct and Dominant Transcriptional Activator of Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus.
Baroja ML; Herfst CA; Kasper KJ; Xu SX; Gillett DA; Li J; Reid G; McCormick JK
J Bacteriol; 2016 Oct; 198(19):2732-42. PubMed ID: 27457715
[TBL] [Abstract][Full Text] [Related]
39. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates.
Lee VT; Chang AH; Chow AW
J Infect Dis; 1992 Oct; 166(4):911-5. PubMed ID: 1527429
[TBL] [Abstract][Full Text] [Related]
40. Enterotoxins and toxic-shock syndrome toxin-1 in non-enteric staphylococcal disease.
Marples RR; Wieneke AA
Epidemiol Infect; 1993 Jun; 110(3):477-88. PubMed ID: 8519313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
